I’m broadly interested in any instance where research and practice overlap, i.e., where the ‘rubber meets the road’ and where the world corrects (and is often corrected by) theory. I currently have three overarching research ‘programs’ that often overlap: (1) side effects and their discovery, (2) public engagement and participation in science/medicine and (3) lessons to/from medicine to/from agriculture.
Below, you’ll find a list of my published/forthcoming works including links to some pre-prints, as well as a list of my current works in progress. Under ‘on the horizons’ you’ll find my more nascent research ideas – if you’re interested in collaborating or discussing those or any other works, please do reach out!
For the most updated access to published/forthcoming work see my philpapers page here. If you have a hard time finding pre-prints for a particular paper please reach out.
Published Work:
[9] Due, A. 2026. “Not Distinctly Harmless, but No Distinct Harms?” Current Opinion in Psychology 10.1016/j.copsyc.2025.102159.
[8] Due, A. 2026. “Double-Effect Sedation and the Importance of Conceptual Clarity in Discussing Side Effects.” Journal of Medical Ethics 52, 308-309. https://doi.org/10.1136/jme-2025-111284.
[7] Due, A. 2025. “Symptom Bias: Definition, Identification, and Avoidance.” Journal of Evaluation in Clinical Practice 31.4. https://doi.org/10.1111/jep.70176. Pre-print here.
[6] Due, A. 2025. “Noisy Nocebo Harms: A Two-Part Problem for Active Drug Surveillance.” Journal of Pharmaceutical Health Services Research https://doi.org/10.1093/jphsr/rmaf002. Pre-print here.
[5] Due, A. 2025. “Patient Participation & Empowerment in Precision Medicine.” Perspectives in Biology and Medicine. https://doi.org/10.1353/pbm.2025.a953451. Pre-print here.
[4] Due, A. 2025. “Is There a ‘Best’ Way for the Public to Participate in Pharmacovigilance?” Journal of Medicine and Philosophy. https://doi.org/10.1093/jmp/jhae038 Pre-print here.
[3] Due, A. 2024. “Sins and Risks in Underreporting Suspected Adverse Drug Reactions.” Philosophy of Medicine 5.1. https://doi.org/10.5195/pom.2024.181. Pre-print available here.
[2] Due, A. 2023. “What are Side Effects?” European Journal for Philosophy of Science 13.1. https://doi.org/10.1007/s13194-023-00519-8. Pre-print here.
[1] Due, A. 2022. “Are ‘Phase IV’ Trials Exploratory or Confirmatory Experiments?” Studies in History and Philosophy of Science 95, 126-133. https://doi.org/10.1016/j.shpsa.2022.07.006. Pre-print here.
Work Under Review/In Progress:
“Does Talk Therapy Have Side Effects?”
“Precision Agriculture and (Modest) Crop Yields: A Role for Regulation?”
“Access to Services ≠ Access to Care: The Case of Pharmaceutical-Telehealth Partnerships.”
“What are Drugs?”
“Acetaminophen, Autism, and Fear Mongering Using Side Effects.”
On the Horizon:
“The Exploratory Values of Medical Conspiracies” (an argument suggesting that conspiracy theories – even those that are seriously ungrounded – may have some value for exploratory medical research)
“‘No Known Side Effects’: Why isn’t Tafamidis’ Label Updated?” (an investigation into why tafamidis - a drug for ATTR-CM/ATTR-PN – is still marketed as ‘having no known side effects’ even though various reports to the contrary exist).
“What Rural Medicine Tells Us About Autonomy.” (an argument that focusing on rural contexts in biomedical ethics reveals that many cases that we think are governed by bioethical principles like ‘autonomy’ are actually more closely governed by an adjacent bioethical principle, ‘justice’).
“Empathy and Symptom Bias” (an argument for how symptom bias – a bias of means-ends reasoning in prescribing practices – is instrumental in ongoing educational movements to encourage empathy in clinicians).